William Blair Initiates Coverage On Apellis Pharmaceuticals with Outperform Rating

Benzinga · 10/16 13:59
William Blair analyst Lachlan Brown initiates coverage on Apellis Pharmaceuticals (NASDAQ:APLS) with a Outperform rating.